Tellus Therapeutics Secures Seed Financing To Develop The First Treatment For Newborns With White Matter Brain Injury

PRIVATEMay 12, 2021

Round Type

Seed

DurhamBiotechnologyHealthcareHealth Care

Description

Tellus Therapeutics, Inc., a biopharmaceutical company developing TT-20 as a treatment for white matter injury (WMI) and myelin repair in premature babies, today announced a seed investment from Xontogeny, LLC to advance their lead program through IND-enabling work.

Quick answer

Tellus Therapeutics raised an undisclosed amount in a Seed round, dated May 12, 2021. Tellus Therapeutics is based in Durham, North Carolina, United States.

How much did Tellus Therapeutics raise?: Tellus Therapeutics raised an undisclosed amount in a Seed round on May 12, 2021.
What does Tellus Therapeutics do?: Tellus Therapeutics is a neonatal care company developing safe and effective interventions for unmet needs of newborns.
Where is Tellus Therapeutics based and how big is it?: Tellus Therapeutics is based in Durham, North Carolina, United States.

Source: Fundz verified event record.

Who else raised in Healthcare and Biotechnology around the same time

Companies in the same sectors as Tellus Therapeutics that raised within 45 days of this round, from Fundz verified event records.

Arbutus raised $81M on June 23, 2021.
Zevra Therapeutics, Inc. raised $39M on June 22, 2021.
Fractyl Health raised $100M on June 22, 2021.
Greenbrook TMS raised $24M on June 21, 2021.
Korsana Biosciences raised $18M on June 17, 2021.
Fractyl Health raised $100M (Series F) on June 16, 2021.

Who to call at Tellus Therapeutics, and when

A new round usually means Tellus Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

An alert the day Tellus Therapeutics raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Tellus Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Tellus Therapeutics. With Fundz connected, it knows.

Watch Fundz in

See plan options

Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Tellus Therapeutics

Location

517 SUMMIT TRAIL DRIVE

Durham, North Carolina, United States

About

Tellus Therapeutics is a neonatal care company developing safe and effective interventions for unmet needs of newborns. Founded in October 2018, Tellus is translating breakthrough science licensed from Duke University that originated in board-certified neonatologist Dr. Eric Benner’s research laboratory together with collaborator and Tellus scientific co-founder Dr. Simon Gregory. Dr. Benner’s work identified compounds in breast milk that induce the regeneration of myelin-producing oligodendrocytes and repair WMI in animal models of perinatal brain injury. Tellus’s goal for its lead asset, TT-20, is to provide a treatment for every baby born at risk for brain injury and to improve neurodevelopmental outcomes for affected children. For more information, visit www.tellustherapeutics.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Tellus Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Book a demo Explore plans

Predictive Intelligence

Strategic

ML-powered predictions for Tellus Therapeutics's next move

See what Strategic adds

Tellus Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

Show me how a sales rep uses this Or see plans and pricing →

5 screens from a live account. No signup.